• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.79% Nasdaq Up 0.53%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.47 Jul 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.47
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:7.70
    Beta:0.33
    Earnings Date:Jul 30 - Aug 3 (Est.)
    Day's Range:N/A - N/A
    52wk Range:3.26 - 6.28
    Volume:0
    Avg Vol (3m):2,692,870
    Market Cap:1.08B
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNA 0.00%1.08B
    GSK101.77B
    OREX617.33M
    RHHBYN/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback